Invokana 300mgAn Invokana lawsuit filed in Canada is seeking $1 billion in damages from Janssen Pharmaceuticals, as well as class-action status from the Ontario Superior Court of Justice, which is expected to rule on the matter later this year.
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

March 21, 2016 – The complaint alleges that Janssen did not conduct sufficient long-term studies regarding Invokana’s effect on the kidneys, and failed to adequately warn of the drug’s potential health risks, which include:

  • Diabetic ketoacidosis (DKA, Diabetic Acidosis, Metabolic Acidosis, Ketoacidosis)
  • Kidney Damage / Renal Failure
  • Heart Attack
  • Stroke
  • Urinary Tract Infections (UTIs)
  • Bone Fractures
  • Fungal Infections
  • Yeast Infections
  • And more

According to the lawsuit, plaintiff began taking Invokana in 2014, and was subsequently diagnosed with kidney failure after learning about the side effect on an American television commercial. Plaintiff claims she would have never considered taking the drug had she been aware of the risks involved. Numerous lawsuits alleging similar injuries from Invokana have also been filed in the U.S.

SGLT2 Inhibitor Diabetes Drugs May Cause Ketoacidosis: FDA Warning

On May 15, 2015, FDA issued a warning regarding the link between use of SGLT2 inhibitor diabetes drugs like Invokana and ketoacidosis, a condition that occurs when cells in the body are unable to get the sugar (glucose) they need for energy because there is not enough insulin. If left untreated, ketoacidosis can lead to diabetic coma (passing out for long periods of time) and even death.
A search of the FDA Adverse Event Reporting System (FAERS) database revealed at least 20 cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients who took SGLT2 inhibitors between March 2013 and June 6, 2014. Ketoacidosis does not typically occur in type 2 diabetics, according to the FDA, and the case presentations were “atypical in that glucose levels were only mildly elevated at less than 200 mg/dL in some reports, while patients with type 1 diabetes who have DKA typically have glucose levels greater than 250 mg/dL.”
Signs and symptoms of ketoacidosis include difficulty breathing, nausea, vomiting, abdominal pain, confusion, unusual fatigue and sleepiness. “Healthcare professionals should evaluate for the presence of acidosis, including ketoacidosis, in patients experiencing these signs or symptoms; discontinue SGLT2 inhibitors if acidosis is confirmed; and take appropriate measures to correct the acidosis and monitor sugar levels,” according to the FDA.

Do I Have an Invokana Lawsuit?

The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Confidential Case Evaluation: Again, if you were harmed by Invokana, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

FREE Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.